Content related to Why do some neuroblastoma patients have “dancing eyes”?

One toy can make a world of difference. After nearly three years of extended stays at Children’s Hospital Los Angeles, this was one of the most enduring takeaways for 6-year-old Valentino Ricciotti

Investigators at Children’s Hospital Los Angeles have found that chemotherapy-induced hearing loss may also contribute to long-term neurocognitive deficits in pediatric brain tumor survivors.

A recent study found that the growth factor G-CSF, used in high-risk neuroblastoma treatment, leads to increased tumor growth and metastasis. Investigators think the benefits still outweigh the risks.

What You Need to Know About Motion Sickness

Kawasaki disease, sometimes called Kawasaki syndrome, is a serious inflammation of the blood vessels which affects young children, often under 5 years of age.

Medulloblastoma, the most common malignant brain tumor occurring in children, is a fast-growing cancer that affects nearly 2 million people – including adults – annually. Traditionally

Early treatment can help overcome this life-threatening condition in premature infants.